Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 65862-863

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 65862-863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Dalfampridine Fig1)

This is a description of the results obtained from study/trial number 1, in which the average change in walking speed was measured during a double-blind phase. The data is presented in Figure 1 as a graph that shows the average percent increase in walking speed from baseline. The placebo group, consisting of 72 participants, is represented by the "0%" bar. The "D st tables 10 mg b.id" group, consisting of 224 participants, is represented by the "%" bars ranging from 20-60%.*

FDA Label Image

Figure 2 (Dalfampridine Fig2)

FDA Label Image

Package Label-principal Display Panel (10 mg (60 Tablets Bottle))

This is a medication named Dalfampridine, available in extended-release tablets of 10 mg each. The tablets are film-coated and should not be divided, crushed, chewed or dissolved. The dispenser is required to provide a medication guide to each patient separately. The manufacturer is Aurobindo Pharma USA, Inc. Each package contains 60 tablets and should be stored in a container with a child-resistant closure at a temperature of 20° to 25°C (68° to 77°F). The package insert should be consulted for dosage instructions. The medication is available only with a prescription.*

FDA Label Image

Chemical Structure (Dalfampridine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.